Part 12/Chapter 64/8-min read

Abdominal and Pelvic Vascular Trauma

Abdominal and pelvic vascular trauma is managed by matching physiology, injury territory, and institutional capability to a source-control sequence. REBOA may create time for definitive control in selected patients, but current guidance, randomized evidence, and registry data argue against broad survival claims. Pelvic fracture hemorrhage, penetrating abdominal vascular injury, and high-grade liver injury require separate reasoning rather than a single aortic-occlusion narrative.

Revision history

Listen to this chapter6 min · AI audio edition · two hostsAI narration

Choose a chapter overview or a specialist discussion. Each recording follows this published edition.

General medical education, not patient-specific advice.

Choose an audio edition

Definition and presentation

Abdominal and pelvic vascular trauma presents primarily as hemorrhagic shock secondary to non-compressible torso bleeding. The physiology mandates rapid differentiation between compressible sources and non-compressible sources requiring operative or endovascular control. Compressible external, extremity, and junctional bleeding is managed by direct pressure, local packing, or tourniquet application. Non-compressible abdominal and pelvic bleeding is managed through systemic damage-control resuscitation and rapid operative or endovascular source control. Clinical severity ranges from transiently responsive hypotension to profound exsanguination, coagulopathy, and traumatic cardiac arrest.

Resuscitation and initial stabilization

Damage-control resuscitation proceeds with mechanical source control: activate the major-hemorrhage protocol, give blood products promptly, prevent hypothermia and correct coagulopathy. Restrict crystalloid rather than withholding needed blood. For suspected pelvic ring disruption, apply a pelvic binder promptly.

Before bleeding is controlled, the European guideline recommends 80–90 mmHg, approximately MAP 50–60 mmHg, in patients without brain or spinal injury; severe ( 8 or below) instead requires MAP at least 80 mmHg. These are Grade 1B and Grade 1C recommendations, respectively. The hemoglobin target of 70–90 g/L is Grade 1C and must not be used to delay transfusion during active major bleeding .

Initial component therapy follows the local major-hemorrhage protocol, then laboratory or viscoelastic findings. A 1:1:1 plasma:platelet: approach is an option, not the only accepted regimen. In PROPPR, 1:1:1 versus 1:1:2 improved hemostasis and reduced early exsanguination deaths but did not significantly improve the primary 24-hour or 30-day mortality outcomes .

Treatment-choice decision

Definitive control uses laparotomy, pelvic stabilization, packing, embolization or vascular repair. During abdominal exploration, direct or supraceliac aortic clamping provides open proximal control; descending thoracic clamping belongs to selected resuscitative-thoracotomy pathways. is an alternative temporary inflow-control technique for selected subdiaphragmatic bleeding, not a substitute for these operations . EAST 2025 conditionally recommends against REBOA in hemodynamically unstable trauma with suspected subdiaphragmatic bleeding, but conditionally favors it over resuscitative thoracotomy in traumatic cardiac arrest from suspected subdiaphragmatic bleeding when no other indication for thoracotomy exists; both conclusions have very-low-certainty evidence . Do not assume that an inflated balloon makes interfacility transfer safe. The JTS protocol calls for hemorrhage control and balloon deflation before ordinary transport and prohibits transfer with complete zone 1 occlusion. Its exceptional partial-occlusion or selected short-distance zone 3 transport pathways require specialist personnel, monitoring and a predefined receiving operation; they are not a general civilian transfer recommendation. The decision to deploy an aortic balloon relies on identifying a bleeding territory anatomically compatible with occlusion, confirming safe arterial access, and naming the exact definitive control maneuver before inflation. Occlusion zone must match the bleeding territory. Zone 1 runs from the origin of the left subclavian artery to the celiac axis and is occluded for intra-abdominal or unlocalized infra-diaphragmatic hemorrhage. Zone 2 is the paravisceral segment from the celiac artery to the lowest renal artery, a no-occlusion zone. Zone 3 runs from the lowest renal artery to the aortic bifurcation and is occluded for isolated pelvic or junctional hemorrhage . A transient hemodynamic improvement following occlusion indicates increased afterload and upstream pressure, but accrues downstream ischemic risk and does not constitute definitive hemorrhage control.

ClassificationAbdominal and pelvic trauma source-control pathways
  • Extremity, external, or junctional
    Primary definitive action
    Direct pressure, local packing, tourniquet
    Adjuncts and bridge role
    Aortic occlusion is contraindicated for compressible local hemorrhage
    Citation
  • Penetrating abdominal vascular
    Primary definitive action
    Immediate damage-control laparotomy, direct vascular control
    Adjuncts and bridge role
    Aortic occlusion is reserved for pre-incision crashing patients with infra-diaphragmatic bleeding; it is abandoned if it delays laparotomy
    Citation
  • Severe pelvic fracture
    Primary definitive action
    Pelvic binder, preperitoneal packing, fixation, or angioembolization
    Adjuncts and bridge role
    Endovascular bridge is conditionally used to shorten the interval to packing or embolization
    Citation
  • High-grade liver injury
    Primary definitive action
    Damage-control laparotomy, packing, Pringle maneuver, selective embolization
    Adjuncts and bridge role
    Aortic occlusion carries high risk due to complex venous and portal anatomy
    Citation
  • Renal arterial bleeding
    Primary definitive action
    Stable or stabilized: contrast CT-based nonoperative care with selective embolization for appropriate arterial bleeding
    Adjuncts and bridge role
    Nonresponding instability, pedicle avulsion or uncontrolled major venous bleeding requires operative control
    Citation
  • Main renal artery dissection or occlusion
    Primary definitive action
    Urgent renal-salvage assessment; selected early endovascular revascularization in a specialist center
    Adjuncts and bridge role
    The WSES less-than-240-minute ischemia criterion is a weak GoR 2C selection recommendation, not a guaranteed salvage window
    Citation
  • Splenic vascular injury
    Primary definitive action
    Stable adult with arterial blush: splenic artery embolization where available; selected grade IV–V injuries merit angiography/embolization even without blush
    Adjuncts and bridge role
    Nonoperative care requires monitoring and immediate rescue capability; deterioration requires definitive hemorrhage control. Do not extrapolate adult grade-only criteria to children
    Citation
  • Unsurvivable injury or prolonged arrest
    Primary definitive action
    Palliation or cessation of resuscitation
    Adjuncts and bridge role
    No intervention is the indicated pathway; temporary maneuvers provide no survival benefit
    Citation

The endovascular trauma pathway executes a structured source-control sequence:

  1. Identify the bleeding phenotype: Confirm non-compressible torso hemorrhage and failure of initial resuscitation.
  2. Define the exit strategy: Select the primary definitive maneuver (laparotomy, pelvic packing, embolization, or vascular repair) prior to securing access.
  3. Establish access: Obtain ultrasound-guided common femoral access without delaying operative incision.
  4. Deploy and bridge: Position and inflate the endovascular balloon to temporarily reduce inflow while the definitive maneuver is performed.
  5. Reassess and deflate: Transition to partial or complete deflation immediately upon achieving definitive surgical or endovascular control.

Pelvic and penetrating injury pathways

Pelvic fracture hemorrhage involves mixed arterial, venous, and cancellous bone bleeding exacerbated by pelvic volume expansion. Aortic occlusion temporarily reduces arterial inflow but does not mitigate pelvic volume, venous bleeding, or bone hemorrhage. Definitive control relies on mechanical stabilization, packing, and selective embolization .

Penetrating abdominal vascular trauma presents a distinct anatomical problem defined by direct vessel injury, hollow-viscus contamination, and time-critical surgical exposure. In shocked patients with penetrating injuries, rapid laparotomy remains the primary intervention, with proximal control secured by direct or supraceliac aortic clamping and the injured vessel managed by temporary intravascular shunting, ligation, or definitive repair according to the patient's physiology. At laparotomy the retroperitoneal hematoma zone directs exploration. Zone 1 (central-medial: aorta, , proximal visceral vessels) is explored for both blunt and penetrating mechanisms. Zone 2 (perinephric and flank) requires exploration for expanding or pulsatile hematoma or uncontrolled renal hemorrhage. Stable non-expanding blunt hematomas are generally left undisturbed. Adequately imaged, selected lateral penetrating renal injuries may also undergo nonoperative management; an inadequately assessed penetrating retroperitoneal hematoma, especially with peritoneal entry, still requires exploration . Zone 3 (pelvic) is explored for penetrating injury; stable blunt pelvic hematomas are not opened and are managed by packing, fixation, and angioembolization . Endovascular maneuvers are used only when access is immediate and the maneuver accelerates transition to open exposure. Balloon deployment that delays abdominal incision or prolongs resuscitation bay time in penetrating trauma worsens outcomes .

High-grade liver injury represents an anatomical boundary phenotype. Hepatic hemorrhage combines arterial, portal venous, and retrohepatic caval bleeding. Altering isolated arterial inflow via aortic occlusion does not control venous or parenchymal exsanguination and is associated with worsened outcomes in registry data .

Post-occlusion management and complications

Reassessment is mandatory following temporary occlusion. The care team monitors continuous physiology, transfusion requirements, and access-site integrity. Occlusion time is tracked explicitly to minimize visceral, spinal, and lower-limb ischemia . After hemorrhage control, the common femoral access site requires formal evaluation for repair or closure, and the distal limb undergoes perfusion surveillance. The patient undergoes staged reassessment for secondary operative reconstruction, , damage-control re-exploration, and mitigation of reperfusion injury .

Areas of controversy

REBOA effectiveness: UK-REBOA randomized 90 severely injured patients aged at least 16 years at 16 UK centers; 89 were analyzed. Ninety-day mortality was 25/46 (54%) with the emergency-department REBOA strategy plus standard care versus 18/43 (42%) with standard care, odds ratio 1.58, 95% credible interval 0.72–3.52; the posterior probability of increased mortality was 86.9%. This does not support routine addition of REBOA and does not establish equivalence to, or superiority over, open aortic clamping .

Pelvic trauma benefit: Observational data and meta-analyses regarding pelvic fracture hemorrhage remain heavily confounded by selection bias. The survival benefit of temporary aortic occlusion over standard damage-control packing and embolization is unresolved, and temporary occlusion carries a real risk of distal ischemic injury .

Penetrating mechanism generalization: The application of endovascular bridge concepts to penetrating abdominal injury relies on observational registry data, and definitive causal proof of benefit over immediate laparotomy is lacking .

EVTM implementation: Open surgery, packing, embolization, covered stents and selected occlusion techniques belong to a coordinated hemorrhage-control service. The 2017 Top Stent Manual and EVTM implementation literature, within the JEVTM educational context, describe integration, training and procedural readiness. This implementation literature is not comparative evidence of a device-related survival benefit .

Further reading

  • Assessing the role of REBOA in the management of hemodynamically unstable pelvic fractures: a systematic review and meta-analysis. (2026). REBOA in unstable pelvic fracture; synthesis limitations do not establish routine benefit.

References

  1. 1.
    AAST/ACS-COT clinical protocol for damage-control resuscitation for the adult trauma patient. Journal of Trauma and Acute Care Surgery. 2024.
    PubMed-indexed article2024

    AAST/ACS-COT clinical protocol for damage-control resuscitation for the adult trauma patient. Journal of Trauma and Acute Care Surgery. 2024. doi:10.1097/ta.0000000000004088.

  2. 2.
    ESVS 2025 clinical practice guidelines on vascular trauma. European Journal of Vascular and Endovascular Surgery. 2025.
    PubMed-indexed articleClinical practice guideline2025

    ESVS 2025 clinical practice guidelines on vascular trauma. European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2024.12.018.

  3. 3.
    Resuscitative Endovascular Balloon Occlusion of the Aorta in surgical and trauma patients: a systematic review, meta-analysis and practice management guideline from the Eastern Association for the Surgery of Trauma. 2025.
    PubMed-indexed articleClinical practice guideline2025

    Resuscitative Endovascular Balloon Occlusion of the Aorta in surgical and trauma patients: a systematic review, meta-analysis and practice management guideline from the Eastern Association for the Surgery of Trauma. 2025. doi:10.1136/tsaco-2024-001730.

  4. 4.
    Western Trauma Association critical decisions algorithm for REBOA. Journal of Trauma and Acute Care Surgery. 2022.
    PubMed-indexed article2022

    Western Trauma Association critical decisions algorithm for REBOA. Journal of Trauma and Acute Care Surgery. 2022. doi:10.1097/ta.0000000000003438.

  5. 5.
    REBOA in penetrating abdominal vascular injuries. American Journal of Surgery. 2025.
    PubMed-indexed articleRegistry / cohort2025

    REBOA in penetrating abdominal vascular injuries. American Journal of Surgery. 2025. doi:10.1016/j.amjsurg.2024.116122.

  6. 6.
    Assessing the role of REBOA in the management of hemodynamically unstable pelvic fractures: a systematic review and meta-analysis. 2026.
    PubMed-indexed articleMeta-analysis / systematic review2026

    Assessing the role of REBOA in the management of hemodynamically unstable pelvic fractures: a systematic review and meta-analysis. 2026. doi:10.1007/s00068-026-03105-8.

  7. 7.
    REBOA in high-grade liver injury. American Journal of Surgery. 2025.
    PubMed-indexed articleRegistry / cohort2025

    REBOA in high-grade liver injury. American Journal of Surgery. 2025. doi:10.1016/j.amjsurg.2024.116174.

  8. 8.
    REBOA and mortality in hemorrhagic shock with severe pelvic fracture. BMC Emergency Medicine. 2024.
    PubMed-indexed articleRegistry / cohort2024

    REBOA and mortality in hemorrhagic shock with severe pelvic fracture. BMC Emergency Medicine. 2024. doi:10.1186/s12873-024-01020-y.

  9. 9.
    REBOA in shocked penetrating abdominal trauma patients. Trauma Surgery & Acute Care Open. 2025.
    PubMed-indexed articleRegistry / cohort2025

    REBOA in shocked penetrating abdominal trauma patients. Trauma Surgery & Acute Care Open. 2025. doi:10.1136/tsaco-2024-001740.

  10. 10.
    Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage. 2023.
    PubMed-indexed articleRandomized controlled trial2023

    Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage. 2023. doi:10.1001/jama.2023.20850.

  11. 11.
    Matched cohort study of REBOA in severe pelvic fracture. American Journal of Surgery. 2023.
    PubMed-indexed articleRegistry / cohort2023

    Matched cohort study of REBOA in severe pelvic fracture. American Journal of Surgery. 2023. doi:10.1016/j.amjsurg.2022.09.057.

  12. 12.
    Top Stent Manual: The Art of EndoVascular Hybrid Trauma and Bleeding Management. 2017. EVTM/JEVTM context source.
    Textbook referenceTextbook2017

    Hörer TM, DuBose JJ, Reva VA, Matsumoto J, Matsumura Y, Falkenberg M, Delle M, Skoog P, Pirouzram A, Brenner M et al. Top Stent Manual: The Art of EndoVascular Hybrid Trauma and Bleeding Management. 1st ed. Örebro, Sweden: Örebro University Hospital; 2017.

  13. 13.
    Endovascular Resuscitation and Trauma Management (EVTM)—Practical Aspects and Implementation. Shock. 2021.
    PubMed-indexed articleClinical practice guideline2021

    Hörer TM, Pirouzram A, Khan M, Brenner M, Cotton B, Duchesne J, Ferrada P, Kauvar D, Kirkpatrick AW, Ordoñez C, Perreira B, Roberts DJ et al. Endovascular Resuscitation and Trauma Management (EVTM)-Practical Aspects and Implementation. Shock. 2021;56(1S):37-41. doi:10.1097/SHK.0000000000001529. PMID:32080064.

  14. 14.
    Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023;27(1):80.
    PubMed-indexed article2023

    Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N, Duranteau J, Filipescu D, Grottke O, Grønlykke L, Harrois A, Hunt BJ, Kaserer A, Komadina R, Madsen MH, Maegele M, Mora L, Riddez L, Romero CS, Samama CM, Vincent JL, Wiberg S, Spahn DR. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023;27(1):80. doi:10.1186/s13054-023-04327-7.

  15. 15.
    Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma: The PROPPR Randomized Clinical Trial 2015-02-03.
    PubMed-indexed article2015

    Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma: The PROPPR Randomized Clinical Trial 2015-02-03. doi:10.1001/jama.2015.12.

  16. 16.
    Joint Trauma System Clinical Practice Guideline: REBOA for Hemorrhagic Shock, CPG ID 38 2025-12-03; accessed v1.4 file dated 2026-04-03.
    JTS CPG2025
  17. 17.
    Kidney and uro-trauma: WSES-AAST guidelines 2019.
    DOI publisher route2019

    Kidney and uro-trauma: WSES-AAST guidelines 2019. doi:10.1186/s13017-019-0274-x.

  18. 18.
    Follow-up strategies for patients with splenic trauma managed non-operatively: the 2022 WSES consensus document 2022-10-12.
    PubMed-indexed article2022

    Follow-up strategies for patients with splenic trauma managed non-operatively: the 2022 WSES consensus document 2022-10-12. doi:10.1186/s13017-022-00457-5.

Educational use only

AI assists this editorial workflow. Published updates are human-reviewed before publication.

Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.

Verify clinically relevant information against primary sources and current guidelines.

Updates and feedback

You are reading the published chapter.

What has changed

Loading the change history…

Report a problem